Pharmaceutical Technology

MAY 13, 2024

As the debate over using tau levels to guide patient treatment persists, the landscape for Alzheimer’s diagnostics continues to move ahead.

52

52

STAT

NOVEMBER 30, 2023

You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s. Worried about your health?

Labelling 119

Labelling FDA 119

Pharmacy Times

AUGUST 29, 2023

Pharmacists can actively engage in the implementation of the Comprehensive Diagnostics and Examinations in Acute Coronary Syndromes pathway within the hospital or health care system.

Hospitals 122

Hospitals 122

STAT

MARCH 5, 2024

After 18 months of debate, the World Trade Organization failed to adopt a controversial proposal to waive intellectual property protection for Covid-19 diagnostics and treatments, ending a furious attempt by civil society groups to bolster global access to needed medical products. The failure was not a surprise.

Vaccines 116

Vaccines 116

STAT

DECEMBER 9, 2023

“ Diagnostic tests for rare conditions present a mathematical conundrum ,” by Manil Suri and Daniel Morgan Read the rest… STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues.

93

93

pharmaphorum

OCTOBER 6, 2023

Empowering health through innovation: Smartwatches as diagnostic aids Mike.Hammerton Fri, 06/10/2023 - 08:00 Bookmark this

113

113

STAT

OCTOBER 4, 2023

The consumer watchdog group the Center for Science in the Public Interest filed a lawsuit against a diagnostics company called EpicGenetics on Wednesday, alleging that the company is making false and misleading claims in marketing its blood tests for fibromyalgia and other diseases.

Insurance 120

Insurance Hospitals 120

STAT

OCTOBER 12, 2023

LONDON — European regulators on Thursday detailed their demands that Illumina divest the cancer diagnostics firm Grail, the latest fallout from the sequencing giant’s troubled 2021 acquisition. The move was just the most recent regulatory action against the deal.

112

112

STAT

JANUARY 18, 2024

New research published Thursday in Science has identified proteins present in the blood of people with long Covid that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets.

Immunization 145

Immunization 145

Roots Analysis

SEPTEMBER 4, 2023

The need to focus on developing more efficient interventions, within stipulated timelines and budget constrains is the key driver for outsourcing operations to third-parties and the diagnostics development space is no exception.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

FEBRUARY 13, 2024

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out of Roche’s acquisition of Venta Medical Systems in 2008.

69

69

pharmaphorum

FEBRUARY 14, 2024

UK patients very concerned about access to diagnostics Phil.Taylor Wed, 14/02/2024 - 10:41 Bookmark this

69

69

pharmaphorum

NOVEMBER 8, 2021

The aim is to “digitise diagnostics care” across the NHS, reducing the time it takes to diagnose health problems and get treatment started earlier, helping to address the massive backlog in care caused by the pandemic, according to a Department of Health and Social Care (DHSC) statement.

Hospitals 111

Hospitals Vaccines 111

Pharmafile

DECEMBER 20, 2023

Owkin and Merck, known as MSD outside of the US and Canada, have announced that they have entered into a collaboration agreement for the development and commercialisation of AI-powered digital pathology diagnostics for the European Union (EU) market.

59

59

Drug Store News

JULY 21, 2023

The market for at-home diagnostics is projected to surpass $8.15 billion by 2030, with pharmacies expected to capture significant revenue share.

97

97

Fierce Healthcare

AUGUST 18, 2023

At-home diagnostics startup Viome Life Sciences snagged $86.5 At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores. |

98

98

Hospital Pharmacy Europe

APRIL 5, 2023

While AI models are being increasing used for a range of healthcare applications, the evidence for a beneficial effect on clinician diagnostic performance is spare. When compared with clinicians, the odds ratio for diagnostic error of the AI models was 0.79 (95% CI, 0.48 – 1.31 p  = 0.36) for hip fracture radiographs.

Hospitals 98

Hospitals 98

The FDA Law Blog

MARCH 19, 2024

is pleased to announce that Director Allyson Mullen has been appointed to the Board of Directors of the Association of Medical Diagnostic Manufacturers (AMDM). Mullen’s extensive experience and contributions to the field of in vitro diagnostic (IVD) regulation. (HP&M), the largest dedicated food and drug law firm in the U.S.,

FDA 59

FDA 59

pharmaphorum

OCTOBER 4, 2022

The FDA has approved Swiss pharmaceutical company Roche’s first companion diagnostic for identifying those patients with HER2 low-metastatic breast cancer who are eligible for ENHERTU. The post Roche gets FDA approval for HER2 breast cancer diagnostic appeared first on. HER2 is a receptor protein that accelerates cancer cell growth.

FDA 105

FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

APRIL 1, 2024

Discover the innovative patent by Jubilant Pharmova Ltd for a stable radiopharmaceutical composition of tetrofosmin, ensuring high purity and effectiveness in diagnostic imaging.

52

52

STAT

DECEMBER 5, 2022

Congress is considering two measures that modernize tools the Food and Drug Administration uses to oversee two areas of its vast portfolio: diagnostic tests and cosmetics. While the stakes are different for each of these industries, the basic premise driving these measures is the same. Read the rest…

FDA 95

FDA 95

pharmaphorum

APRIL 29, 2022

” It comes as the UK is facing something of a crisis in the NHS as it tries to tackle a backlog of cancer diagnostic procedures that built up during the pandemic, while access to healthcare services was reduced. ” The post Smartphone-based skin cancer diagnostic certified for use in UK appeared first on.

Hospitals 145

Hospitals 145

STAT

JULY 14, 2023

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

90

90

pharmaphorum

SEPTEMBER 24, 2020

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. The post Cognoa preps FDA filing for digital autism diagnostic appeared first on. Photo by natsuki on Unsplash.

FDA 134

FDA 134

pharmaphorum

JANUARY 31, 2022

People with long-lasting symptoms of breathlessness after COVID-19 infection may have damage to their lungs that does not show up using routine diagnostic scans, according to a small UK study. The post New diagnostic finds hidden lung damage in long COVID appeared first on.

111

111

PharmaShots

JUNE 14, 2023

Shots: Impelled by interminable technological advances and unceasing innovations, diagnostic and testing companies hold potent positions in the healthcare industry. Varex’s 2022 diagnostic segment revenue increased by 4.69% as compared to 2021. Grifols’ 2022 diagnostic segment revenue dipped by 18.18% as compared to 2021.

FDA 56

FDA Hospitals Documentation Patient Care 56

pharmaphorum

NOVEMBER 10, 2022

Preventive and diagnostic care is key to building more inclusive and resilient systems and procedures for the healthcare sector, but we have a long way to go before this vision becomes reality. Preventive vs. diagnostic care. Both prevention and diagnostics have a significant role to play in building the future of healthcare.

Vaccines 97

Vaccines 97

Fierce Pharma

NOVEMBER 16, 2023

By Yuri Fesko, MD | Our latest white paper, delves deep into the symbiotic relationship between diagnostic labs, pharmaceutical companies, and healthcare providers in the era of precision medicine.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Outsourcing Pharma

AUGUST 2, 2023

Susan Wood is CEO and president of VIDA Diagnostics. She has over 25 years of experience championing clinical intelligence solutions into routine clinical use.

83

83

Outsourcing Pharma

SEPTEMBER 11, 2023

Glasgow diagnostics spinout Microplate Dx has closed a Â2.5 million seed funding round to develop its point-of-care diagnostic platform, which can confirm the presence of bacteria and rapidly identify effective antibiotics to use and which ones to avoid.

52

52

Fierce Healthcare

FEBRUARY 23, 2023

VisualDx's diagnostic support tool to be available to all AMWA members agliadkovskaya Thu, 02/23/2023 - 16:25

97

97

Pharmaceutical Technology

FEBRUARY 29, 2024

After a challenging few years post-pandemic, industry professionals believe diagnostic testing is back on track

52

52

Fierce Healthcare

DECEMBER 12, 2022

Home ovulation diagnostic startup Proov brings hormone insights to Google Health Connect. Mon, 12/12/2022 - 13:11.

104

104

Pharmacy Times

AUGUST 13, 2023

Entrepreneurs and healthcare retailers can support pharmacists by digitizing the recommendation model and closing the diagnostic gap.

65

65

Fierce Healthcare

OCTOBER 10, 2023

A new partnership between Imperial Health Plan of California and Simple HealthKit began offering at-home diagnostic tests for Imperial’s Medicare Advantage (MA) members in September. Imperial Health Medicare Advantage members are now able to test for chronic conditions at-home, ideally before complications arise.

57

57

PharmaVoice

MAY 6, 2024

Tests frequently used in clinical trials will soon be regulated like medical devices — with some exceptions.

84

84

Pharmaceutical Technology

SEPTEMBER 4, 2023

The company published a study showing lyso-Gb1 (glucosylsphingosine) as a diagnostic and predictive biomarker for the rare metabolic disease.

52

52